Pmgc Holdings Inc. income statement ELAB

Annual Quarterly

In fiscal 2025, which ended Dec 31, 2025, Pmgc Holdings Inc. reported revenue of $590,084. It recorded a net loss of $7.7 million.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2026 Jun 30, 2026	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023
Revenue	—	1	—	2
Cost of revenue	—	0	—	2
Gross profit	—	0	—	1
Research and development	0 +173.4%	0 +40.5%	0 +1312.3%	0
Selling, general and administrative	5 +250.3%	2 +104.9%	1 +8.4%	1
Pretax income	—	-8	—	—
Income tax	—	0	—	—
Net income	-13 -140.5%	-8 -24.0%	-6 -45.2%	-4
Basic EPS	-10.09 -100.0%	—	—	-0.40
Diluted EPS	—	—	—	-0.40
Weighted average shares, basic	1 +1316288.7%	0 +2049.1%	0 -87.7%	0
Other measures
Depreciation and amortization	1	0 +642.4%	0 +11.2%	0
Margins
Gross margin	—	31.40%	—	66.25%
Pretax margin	—	-1,313.33%	—	—
Profit margin	—	-1,313.00%	—	-251.17%

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: ELAB (Nasdaq)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Newport Beach, CA
SEC filer status: , Emerging growth company
SEC CIK: 1840563
Former names: Elevai Labs Inc. (until Nov 27, 2024); Reactive Medical Labs Inc. (until Oct 14, 2021)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.